ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,052, issued on July 7, was assigned to Exelixis Inc. (Alameda, Calif.).

"Combinations for the treatment of cancer" was invented by Gisela Schwab (Hayward, Calif.), Christian Scheffold (Palo Alto, Calif.), Colin Chong (Fremont, Calif.), Ssucheng Jeff Hsu (Pinole, Calif.), Peter Lamb (Oakland, Calif.) and Peiwen Yu (San Mateo, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to combinations comprising a checkpoint inhibitor and a c-Met inhibitor, Compound 1. The invention also relates to crystalline forms of the free base of Compound 1, as well as crystalline forms of salts of Compound 1, in combination with a checkpo...